ginsenoside rg3

Botanicalexperimental

Clinical trial activity

4 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Apr 1, 2012 (NCT01717066)

Timeline

2010s

  1. Jan 1, 2012

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    Unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • ginsenoside rg3
  • ginsenoside rg3
  • rg3
  • rg3

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04523467N/ADec 1, 2020Eastern Hepatobiliary Surgery Hospital
NCT01757366Phase 2Dec 1, 2012Hebei University
NCT02724358N/ADec 1, 2012Eastern Hepatobiliary Surgery Hospital
NCT01717066N/AApr 1, 2012Eastern Hepatobiliary Surgery Hospital, Fudan University, Fujian Medical University, Harbin Medical University, Huazhong University of Science and Technology, Sun Yat-Sen University
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Eastern Hepatobiliary Surgery HospitalAcademic/Hospital3312012
Fudan UniversityAcademic/Hospital1012012
Fujian Medical UniversityAcademic/Hospital1012012
Harbin Medical UniversityAcademic/Hospital1012012
Hebei UniversityAcademic/Hospital1112012
Huazhong University of Science and TechnologyAcademic/Hospital1012012
Sun Yat-Sen UniversityAcademic/Hospital1012012
7 organizations
Page 1 / 1